OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Fifteen of top 25 are drug or device makers; hospitals and distributors round out the list
Saying that, by identifying 25 top-performing firms in delivering value across a supply chain from manufacturer to patient in a healthcare setting, AMR Research hopes to raise the importance and recognition of good supply-chain practices throughout healthcare. The Boston market-analysis firm combined quantitative assessments of ROA and inventory turns with qualitative rankings by two panels: a group of outside experts, and the AMR analysts. The company plans to update the list annually while highlighting new, successful innovations.
The Healthcare Top 25 (ranked by their composite scoring):
1. Johnson & Johnson
2. Sisters of Mercy Health System
3. Cardinal Health
4. Owens & Minor
6. CVS Caremark
7. Abbott Laboratories
9. Becton Dickinson
16. Cleveland Clinic
19. Alcon Laboratories
21. Boston Scientific
22. BJC Healthcare System
25. Mayo Clinic
From a biopharma perspective, AMR’s scope is a little unfamiliar: The company defines the healthcare value chain from manufacturer to a patient, but mostly one in a hospital or clinical system—something that directly represents only about a quarter of the biopharma market. Some qualifiers: except for the healthcare systems, AMR limited its analysis to publicly traded firms, which would exclude, among others, privately held wholesalers like HD Smith; it did not include distributors that have large business outside of healthcare (which would have brought distribution companies like UPS Healthcare Logistics into consideration); and, according to AMR chief strategy officer Kevin O’Marah, “rightly or wrongly, we are biased against payers and other intermediaries” which thus excluded PBMs and mail-order pharmacies like Medco (even though the PBM parts of CVS Caremark or Walgreens got in via their retail operations).
Even so, the ranking is sure to generate discussion, at least among biopharma companies who compete head to head, and the longer-term goal, according to AMR VP Hussain Mooraj, is to highlight the efficiencies to be had by better collaboration among trading partners, better sales & operations planning, and a stronger patient focus.